MDGL Market Cap History



Below is a table of the MDGL market cap history going back to 7/25/2016:

Date MDGL Market Cap
7/25/2016115.04M
11/11/2016186.74M
3/24/2017185.19M
5/5/2017194.44M
8/4/2017199.56M
11/3/2017587.42M
3/8/20181.86B
5/3/20181.60B
8/2/20183.86B
11/1/20183.10B
2/21/20191.94B
5/2/20191.63B
8/1/20191.36B
11/1/20191.51B
2/21/20201.43B
5/4/20201.35B
7/31/20201.58B
10/30/20201.97B
2/19/20211.95B
4/30/20212.26B
7/30/20211.45B
11/2/20211.45B
2/21/20221.46B
5/5/20221.14B
8/1/20221.04B
11/1/20221.26B
2/20/20235.50B
5/5/20235.60B
8/3/20233.57B
11/1/20232.69B
2/16/20244.64B
5/3/20244.90B
8/2/20245.98B
10/28/20244.73B

Also see: MDGL Shares Outstanding History
and MDGL YTD Return
MDGL Historical Market Cap:
+56.78% CAGR
MDGL Historical Market Cap: +56.78% CAGR

Mouse over chart for data details
7/25/2016 ...10/28/2024
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). Co.'s product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-? (THR-?) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). Co.'s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES. We show 34 historical shares outstanding datapoints in our MDGL shares outstanding history coverage, used to compute MDGL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MDGL market cap history over the course of time is important for investors interested in comparing MDGL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MDGL versus a peer is one thing; comparing MDGL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MDGL can fluctuate over the course of history. With this page we aim to empower investors researching MDGL by allowing them to research the MDGL market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree MDGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Madrigal Pharmaceuticals (MDGL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

MDT Market Cap History
MDXG Market Cap History
ME Market Cap History
MEDP Market Cap History
MEIP Market Cap History
MGEN Market Cap History
MGLN Market Cap History
MGNX Market Cap History
MGRM Market Cap History
MGTA Market Cap History
More Healthcare companies »

 

MDGL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.